LEAHY, Senior District Judge.
This is a patent infringement suit. The patent (2,441,091) was held valid and infringed (Claims 12 and 24). D.C. Del., 133 F.Supp. 648. The judgment was affirmed (per Biggs, C. J.), 3 Cir., 237 F.2d 594. The trial judge then appointed Irving Morris, Esq., a Master “to take and report an account of such damages” suffered by plaintiff (Philips) by reason of defendant’s (Drew’s) infringement. Facts and technical discussion of the patented process appear in the cited opinions.
The Master’s report is confined to damages. Both sides have filed exceptions to his report.
The Master’s Report.
,
a.
The apposite statute is noted.
The Master recognized § 284 serves as a
guide, but the decisional law has followed several paths: 1. reasonable royalty; 2. established royalty; 3. profits earned by an infringer. Plaintiff urged before the Master certain approaches under the various theories of damages.
Plaintiff argued it was entitled to defendant’s entire gross profits because of commingling the processed product (covered by the patent) with other products sold by defendant and which made it impossible to apportion defendant’s profits from its total sales of
all
its products. Moreover, it was argued, defendant’s mark-ups also form the basis of estimating profits for awarding damages. In addition, treble damages were sought for willful infringement. But defendant argued plaintiff was entitled merely to a reasonable royalty, i. e., to be determined by the established royalty paid to plaintiff by its other outstanding (4) licensed users.
The Master recognized plaintiff's “compensation must not be less than a reasonable royalty for [defendant’s] use of [plaintiff’s] patent.”
Where outstanding license agreements established a royalty, the Master said “it would be arbitrary to disregard [plaintiff’s] own experience in the market place and to accept [plaintiff’s] invitation to speculate about its damages over a range from $358,082, to $1,289,-096.87.”
,
a The Master found it significant that before the instant litigation, plaintiff had offered defendant a license agreement similar to those accepted by other users in the field'. The Master said: “from the standpoint of compensating [plaintiff] as to its damages suffered as a result of [defendant’s] infringement, one can ascertáin its primary damages from [defendant’s] refusal to accept a license from the royalty price (based upon grams of provitamin D3) and the number of millions of international chick units of vitamin D3 produced by [defendant] from [plaintiff’s] patented process, after converting the vitamin D3 units to grams of provitamin D3 assuming a reasonably efficient process, since [defendant’s] operation was admittedly inefficient, multiplying the result by a factor of 3.”
Before the Master, defendant attacked such calculations because damages are recoverable only from the date of notice of infringement.
Defendant suggested further the established royalty rate (found in outstanding licenses) should be reduced because, if guilty, defendant infringed only one patent, whereas the established royalty in outstanding licenses
was based upon two patents and six applications.
The Master concluded: “If established royalties are the measure, the infringer must pay* them whether he infringed one patent or eight patents. [Defendant] having tortiously used the invention, seeks by its argument to place itself in a better position than [plaintiff’s] licensees who lawfully used the invention.”
Finally, defendant contended plaintiff’s multiplication factor was erroneous in computing established royalties. Plumaker for defendant testified a. he had never isolated provitamin D3; b. defendant’s process was uneconomical in making dehydrocholesterol and converting it to vitamin D3; c. the approximate efficiency of converting cholesterol into dehydrocholesterol was 15 to 40 to 50 % ; and, d, the overall process efficiency from cholesterol to vitamin D3 was 10%. The Master found, however, Plumaker’s testimony supported plaintiff’s position; and Watkin’s testimony for plaintiff likewise justified plaintiff’s calculations.
The Master found primary damages of $28,307.47 because he said they were: “based upon the reasonable royalty which [plaintiff] would have been entitled to receive and would have received from [defendant], had a license agreement with its established royalties been in effect between the parties during the period of infringement.”
Plaintiff at all times sought treble damages, attorney’s fees, interest. and costs based upon willful or “grossly careless infringement.” The Master was not-free from doubt because of the statutory language, § 284, whether he had the power to increase damages. But, the Master concluded he had power to award more than primary or base damages if the facts would support such a conclusion.
The Master’s Report
then reads: “The opinions of Chief Judge Leahy and Chief Judge Biggs and the record before me
leave no doubt that defendant’s infringement in the instant case was willful, or, put in the best possible light to defendant, so grossly in disregard of the rights of plaintiff as to amount to willfulness.
“Before trial [defendant] relied on 24 items of prior art. At trial reliance was narrowed to two publications: a. the Wohl, and b. the Ziegler articles. No other ground of invalidity was pleaded nor was other evidence on any other ground introduced at trial. 133 F.Supp. 648, at page 650. Chief Judge Leahy found as a fact that defendant conceded
that ‘Wohl was not concerned with the essential inventive step * * Ibid, at page 651. As to the Ziegler article, Chief Judge Leahy found that it had been before the Patent Examiner and was overcome in the prosecution of the application on which the patent issued. Ibid. As the Court pointed out (Ibid.) defendant conceded that ‘While Ziegler may have suggested a path in the forest, he never pointed it out, nor did he walk down it.’ Chief Judge Leahy concluded: T do not believe a general synthetic organic chemist with no expertise in the chemistry of sterole, given Wohl and Ziegler (nothing else) could produce the substance resulting from the process of the patent by making use of general chemical information. At least no such chemist so testified.’ Ibid. In every particular the opinion of the Circuit Court affirmed Chief Judge Leahy’s findings and conclusions.
“Yet defendant’s only bases for asserting the invalidity of the patent were the two articles by Wohl and Ziegler.
“If an infringer may take unto himself the invention of another without any bona fide or reasonable basis for so doing and run the risk only of having to pay at some future time a reasonable royalty for his use of invention, a premium would be placed upon the act of a wrongdoer, the rights of the inventor under his patent would become illusory,6 and responsible people dealing in the patent field would be encouraged to disregard lawful property rights and participate in a lottery with the winning ticket stamped ‘invalid’.
“Defendant’s claim that it had ‘good reason’ to contest the patent and that it acted in ‘good faith’ (DB18) cannot be squared with the opinion of the District Court and the conclusion of the Circuit Court holding that: ‘There is no question but that defendant has infringed [plaintiff’s patent].’ 237 F.2d at page 596. This is not a case where in good faith a reasonable doubt could have existed in the mind of the infringer. Where an alleged infringer takes an untenable position on the validity of the patent, and, at great expense and damage, the patent owner succeeds in establishing his claim in court, the infringer should bear not only the responsibility of making the patent owner whole, but also a penalty for his contumacious conduct. 35 U.S.C. § 284; Russell Box Co. v. Grant Paper Box Co., supra; Activated Sludge, Inc. v. Sanitary Dist. of Chicago, D.C.N.D.Ill.1946, 64 F.Supp. 25, 34-35, affirmed
per curiam,
7 Cir., 1946, 157 F.2d 517; Livesay Window v. Livesay Industries, Inc., supra. In this case I believe the record as summarized in this report warrants doubling the damages and allowing plaintiff its counsel fees.
“An additional word of explanation is in order with respect to the doubling of damages. In a draft report submitted on July 31, 1959, to the parties pursuant to Rule 53(e) (5) [28 U.S.C.A.], I increased the damages by trebling them. I did so under my then erroneous view that defendant had persisted in infringing plaintiff’s patent after Chief Judge Leahy issued a permanent injunction in September, 1955, which I thought would unquestionably make this case ‘a classic example of a willful and wanton violation of a patent’, i. e., continued infringement despite an order of the court. Because I considered violation of the Court’s order in these circumstances so significant, I considered treble damages entirely warranted. The fact is, however, that by a stipulation in November, 1955, a supersedeas bond was entered having as one effect a postponement of the injunctive order until after a review and adjudication of the case by the Court of Appeals. Since I had ignored the November, 1955 stipulation in arriving at the tentative determination set forth in the draft report, I have reviewed the entire case carefully after receiving sug
gestions from counsel (which, I add, have been most helpful), and I have concluded that the damages shc^ild not be increased by trebling them, but that, based on what unquestionably appears to me as defendant’s lack of good faith in contesting the patent, the damages should be doubled. I add by way of explanation and not of excuse (I, of course, assume full responsibility for the error), that counsel who tried the case before Chief Judge- Leahy and undoubtedly knew of the November, 1955, stipulation, both apparently overlooked the stipulation when they appeared before me. The Record before me reads (R
18):
“ ‘Mr. H. C. Bierman: I am going to object to this line of examination. I don’t think it is at all pertinent here. The fact that we ceased is the only fact that is pertinent.
“ ‘Mr. Connolly: This has a very definite bearing, your Honor, on the question of damages, because the time to which this witness was referring was long after this company was under an injunction, and it bears directly on the wilfulness and the treble damages.
“ ‘This company has been in this business violating the injunction for a long time after it was issued, so I submit it is most material to the issues before your Honor.
“ ‘Mr. H. C. Bierman: The only thing material is the time when we ceased making, as far as this witness is concerned.’
“I conclude, therefore, that defendant should pay plaintiff damages in the amount of $56,614.94 (i. e. plaintiff’s primary damages doubled), its reasonable attorneys fees, which I find to be in the sum of $19,150,7 and its disbursements of $1574.65, interest from the respective dates when royalty payments would have been made by defendant had plaintiff taken a license such as those plaintiff had granted to others, and costs of the case and this proceeding.
“Hereto attached and made a part of this report are the specific Findings of Fact
and Conclusions of Law upon which this report is based.
“Irving Morris “Special Master”
1. The final chapter of this litigation concerns damages. The most recent statement is contained in International Industries, Inc., v. Warren Petroleum Corp., 3 Cir., 248 F.2d 696, 699, where the Court discussed the close analogy between damages for a purloined trade secret and for patent infringement, and held damages are not what a plaintiff lost but rather “the benefits, profits, or advantage gained by the defendant.”
Before 1946, 35 U.S.C.A. § 284 used the word “profits”. The 1952 subsequent codified version
of the patent laws left this out. But, the effect of the elimination
was
considered by the Senate Committee on Patent,
when it stated: “ * * * the bill would not preclude the recovery of profits as an element of general damages * * And cases since have held profits of an infringer are a proper factor in considering damages where other measures are not totally adequate.
Where the commercial value of a product is increased by the use of the patented process and in-
infringement is present, profits are considered a relative element.
This Circuit in defining a reasonable royalty to be an established royalty, as the amount which an infringing party using another’s patent must pay, did not exclude, I think, consideration of all other factors, including the tort-feasor’s profits, in arriving at the patent owner’s damages.
For example, the nature of the invention, its utility, its novelty over and advance in the art, and the extent of its use by the infringer, are entitled to judicial consideration.
2. Damages may be measured by the defendant’s gain or the plaintiff’s loss. Yet, no matter how measured, it can never be less than a reasonable royalty — and, there must be the factor of the infringer’s profits to be considered as one of the elements of measurement.
The factors selected by a Court for application must be determined in any particular case by the facts and circumstances involved, so, as a matter of fairness and equity the plaintiff receives his injunctive relief and sufficient compensation for the wrong done and, so,.defendant may not digest and retain, but must disgorge, his illegal gains. And some Courts have not exercised meticulous care to avoid hardship on the infringer.
There should be no special rule indigenous to a person who commits a patent-tort from the liability of a defendant who takes your automobile, your business or your trust fund. In short, “damages” adequate to compensate for any particular infringement under § 284 should not be based solely on 1. established royalty; or, 2. reasonable royalty; or, 3. profits of an infringer. Cases may be found falling into each of these categories. But this should not be a congealed pattern for recovery, i. e., any particular theory of recovery applied to the exclusion of the remaining two theories of recovery. An enlarging complex of law has sprung from Article 1, Section 8 of the Constitution. This body of law, at least for the last quarter of a century, has been in a state of change. Concepts of invention, and all its allied incidents, (including recoverable damages, I think) present new and special problems, as suggested by one of the writers.
General damages (at law or in equity) are compensatory for the thing taken or the injury sustained. Punitive damages have a specific purpose and meaning. But, the problem in each case is whether a particular plaintiff is entitled to the totality of “the benefits, profits, or advantage gained by the defendant.” International Industries, Inc. v. Warren Petroleum Corp., supra.
3. One measure of damages in infringement cases is on an established royalty basis which is the royalty paid by others in an industry and which indicates a general acquiescence in the value of the invention. In contrast, if a reasonable royalty base is applied, this represents the amount one would pay for the use of the patent as a business proposition, after evaluating the novelty of the invention, its utility and advantages. Faulkner v. Gibbs, 9 Cir., 199 F.2d 635. A reasonable royalty is often higher than an established royalty for the latter is usually based upon agreements negotiated before the patented invention is broadly recognized and before the patent stands the test of judicial scrutiny. The lowest return for a measure of damages would be on the basis of an established royalty.
4. But, here, defendant’s production records before the Master should be increased on a monetary basis to compensate for the admitted inefficiency of defendant’s operations. When this is done, the testimony demonstrates that damages computed even on the basis of established royalties would be about $53,-761.88. To take a reasonable royalty as a measure of damages, a figure of 10% of the sale price of defendant’s vitamin D3 was considered reasonable under the evidence before the Master.
The sales prices of vitamin D3 are in the record. The statute itself provides awarded damages shall in no event be “less than a reasonable royalty”. Since sales of defendant’s products containing D3 could be computed on the total sales figures of $3,580,824.63 — 10% of such figure would be $358,082 to form the basis of a reasonable royalty return.
5. Considering defendant’s profits as a factor to arrive at a figure for plaintiff’s damages, the record before the Master establishes an area between $685,818.90 and $1,289,096.87. The Master made no findings with respect to defendant’s profits, however, because he was of the view it was unnecessary as he based plaintiff’s award on an “established” or “reasonable” royalty base. But the evidence on defendant’s profits as found in the record is not without interest. There was an accounting (The Richards and Ganly Report) which merits examination. Defendant’s president so admitted
The Report is based upon assumptions, conclusions and beliefs— unverified because of absence of defendant’s records.
The spot-tests method was used.
In fact, only “spotty” records were available for the Report
There was an absence of necessary records for computing costs and stating profits.
The Report was so inaccurate its authors would not certify it.
Because there apparently was an accounting confusion as to the type of vitamin units discussed, a significant 4 to 3 error was made in the total production fig-
ares.
A check of the computations revealed arithmetical error.
Errors resulted from the way cost and expenses were constructed and allocated. For example, cost was taken for part of a year and then assumed appliable for the entire year and preceeding year without regard to actual cost and the shifting increase or decrease of cost.
Then percentage of costs was arbitrarily allocated from one year and applied to others.
Variations in both costs and sales were not considered.
As to certain cost and expense items no rates or figures were given — only arbitrary allocations were made.
No cost or expense item of vitamin D3 was segregated by product— vitamin D3 was simply assigned a sharé of cost and expense regardless whether this product was responsible for any portion of that cost or expense.
Even administrative expense was not segregated by division.
In sum, nowhere in the Report is it shown vitamin D3 was responsible for any of the cost or expense attributed to it.
6. Manifestly the basic theory of the accounting Report (allocation of expenses and costs on the basis of dollar volume of sales) lacks probative value since it shows no portion of costs and expenses attributable to vitamin D3. But the Report cannot exculpate defendant for its infringement for 8 years, neither can it be tossed in the judicial waste basket, for it does show for that period sales of vitamin D3 products amounting to $3,-580,824.63. The gross profits of defendant’s sales of products containing vitamin D3 are set forth in the record. For the purposes of this case these figures of defendant’s own selection will be accepted for the finding of an award to go to plaintiff.
7. One accounting expert was of the opinion there were several methods of computing defendant’s profits other than the fictitious reconstruction and allocation of costs used by defendant. An acceptable method would show profits on defendant’s sales of its product
without
vitamin D3 as compared with profits from sales of the same products
with added
vitamin D3.
a Sales of vitamin D3 concentrate alone should have been shown.
,
a But none of this evidence was forthcoming from defendant. In fact, defendant’s president could not explain why defendant stopped keeping records after the suit at bar was started but records were kept after judgment was given for plaintiff.
Defendant was • a “one-man” company. Yet its president paid no attention to the instant litigation,
never attempted to ascertain if his company was infringing,
was never advised when the Court’s injunction was issued.
There is available, however, another method of computing defendant’s profits e. g., defendant’s mark-up of products using vitamin D3. Defendant’s sales records show mark-ups from 22% to 50%
or an average of 36%. In addition, one expert showed mark-ups in the vitamin field of from 60% to 150%.
Dollar volume of sales were shown and with a fair mark-up of only 36% there would result a profit (involving D3 products) of $1,289,096.87. All this is on the basis of defendant’s own records. Where infringement is palpable, the injunctive process issues, and when the established royalty measure of damages is inadequate, a proper measure of damages includes a consideration of profits (not, however, a total award of the profits) as one of the elements gained by the defendant’s illegal use of the patent.
The expert testimony shows a reasonable royalty to be 10% Then there is the Riehards-Ganly Report which shows sales of products containing D3 of $3,-580,824.63. Defendant’s president stated these sales resulted because of the vitamin D3.
Aside from defendant’s substantial profits, a reasonable royalty, on the last figures noted, would be $358,-082. The award by the Master of merely $28,307.47 is obviously “less than a reasonable royalty” and could be said to ■violate the statutory minimum.
8. Much consideration was given by the parties to whether the obvious infringement was willful. It apparently worried the Master, too. He first found the infringement willful enough ■ to treble the base-damages he arrived at. Then after further presentation by the parties he cut it to double damages. The record makes available a narrative which proves the defendant’s infringement was far from accidental. Defendant’s production manager admitted use of the patented process since 1948
when defendant began its large commercial use of plaintiff’s patent
which had issued only a month preceding.
This was no chance use of plaintiff’s process: patent experts, in fact, put defendant’s process in operation.
In 1950 defendant was offered a license under the patent in suit, the same licensed patent as other companies in the industry were operating under.
An analysis of defendant’s behavior pattern of infringement over the years, post and ante suit, offers a choice where reasonable judges could differ on whether the infringement was willful enough to support treble or double damages. In short, decision, in the instant case under the facts, is well within the area of legitimate difference of opinion as to whether plaintiff should have its base-damages multiplied. But, this compensatory technique selected by the Master is not wholly required. Moreover, any recovery based on established royalties is rejected.
The statute itself (§ 284) provides for nothing “less than a reasonable royalty for the use made on the invention by the infringer, together with interest and costs” and the “court may receive expert testimony as an aid
to the determination of damages or of what royalty would be reasonable under the circumstances.” A meticulous calculation of a fair or reasonable patent royalty is for all practical purposes a physical impossibility. The field of economics —where a reasonable royalty lies — is not subject to the uncanny precision of mathematical sciences such as astronomy and electronics, since, unfortunately, business men do not at all times behave like heavenly bodies or charged particles. To strive for such precision would serve only to defeat the judicial purpose. But, here, we have tangible tools to work with. As stated above, there is evidence of a reasonable royalty of 10% and the RichardsGanly Report of total sales or products containing vitamin D3 shows $3,580,824.-63.
A reasonable royalty, taking all other factors and defendant’s profits into consideration, would therefore be $358,-082. Anything less than this minimum would be a violation of the statute for recovery. Such damages are awarded.
9. The Master’s allowance of attorneys fees for plaintiff are approved. The entire record of the case at bar demonstrates it was “exceptional” even in the semantic sense.
The Master provided for the computation of interest, as provided for by the statute, in his Conclusion of Law No. 11. There should be no difficulty for counsel to arrive at an acceptable figure, to be included in the monetary judgment that is to be entered. Damages, as stated, interest, attorneys fees and costs are allowed. Each, party shall be responsible for one-half the allowance made to the Master.
Submit order.
Master’s Findings of Fact
The results of an examination of the Record support the findings of fact of the Master.
(A) Findings of fact Nos. 1, 2, 4, 5, 6, 9 are supported by the Record. Defendant did not object to these. They are adopted. !
(B) Finding 3: defendant objects. The finding is supported by the Record. The finding is adopted.
(C) Finding 7: both plaintiff and defendant agree the figure of $40,321.41, there stated, should be $28,307.47. This correction is adopted.
(D) Finding 8: defendant objects. The finding is supported by the Record. Defendant’s objections are argumentative in nature. The complaint by defendant is, at bottom,, the Master gives a different emphasis to the facts found in the evidence from that which the defendant would give. Weighing the inference-fact-conclusion of the Master and considering it within the range of reasonable limits, the finding should stand, and it is adopted.
(E) Finding 10: defendant objects. Same comment, here, as made in (D) supra, and also diluting the fact-inference of bad faith, the finding is adopted.
(F) Finding 11: defendant objects. Same comment, here, as made in (D) and (E), supra. The finding is adopted.
(G) Finding 12: defendant objects. The findings, here, are supported by the Record. Defendant argues these facts are immaterial and irrelevant to the question of damages. I disagree. The Master’s consideration of these facts was not erroneous. The finding is adopted.
The Court’s Additional Findings of Fact
For a proper decision in the case at bar it is necessary to make additional findings of fact. These are supported in the record before the Master; and they sustain the decision, using a reasonable roy
alty measure after considering defendant’s profits, plaintiff has proven damages, as stated in the foregoing opinion, of $358,082.
13. Plaintiff’s president Drew testified costs were so intermingled they could not be segregated.
14. Defendant’s Plumaker testified defendant never isolated provitamin D3 since defendant’s process (using plaintiff’s patent) of making vitamin D3 was a continuous one.
Because of defendant’s lack of records, failure to segregate costs, failure to keep any process cost records, it is not possible to allocate costs or profits to any particular step in the manufacture of vitamin D3.
Plumaker never tried to compute the cost of making provitamin Ds,
and defendant’s Preusch had trouble finding vitamin D3 costs; he readily admitted defendant kept no cost records in its Vitamin Division and made no effort to segregate costs.
Shanks corroborated this testimony.
Defendant’s president Drew agreed costs were so intermingled they could not be segregated.
15. Preusch gave as one reason for failure to keep cost records on vitamin D3 and failure to segregate expenses to this product was that this product was only a small part of defendant’s business.
Between 1948 and 1956 net annual sales of vitamin D3 varied between $234,050.10 and $541,579.66 while defendant’s entire annual sales varied from $44,516,792 to $88,380,652.
16. Most of the products which contained vitamin D3 were also sold by defendant without the vitamin D3.
17. Defendant’s profits on its sales of products containing vitamin D3 were $685,818.90.
18. Watkins of plaintiff’s licensing department and with broad experience in this field
testified a royalty of 10% of the sale price of defendant’s vitamin D3 is reasonable.
19. Sale prices of vitamin D3 are described and found in the evidence
and the exhibits. Applying a 10% royalty rate, using defendant’s own prices, to the number of units of vitamin D3, in fact, sold by defendant a reasonable royalty results.
20. Since defendant’s sales of products containing D3 resulted solely because of the D3, as even defendant’s president Drew testified,
the reasonable royalty, in the light of defendant’s heavy profits, should be computed on a total sales figure of $3,580,824.63, in an award of damages for plaintiff in the amount of $358,082.